Axitinib pill box instructions
1. Indications (Indications):
Axitinib is a tyrosine kinase inhibitor used primarily to treat renal cell carcinoma (RCC, kidney cancer) in adult patients. It is indicated for patients with advanced renal cell carcinoma who have become resistant to previous first-line treatments.
2. Mechanism of Action (Mechanism of Action):
Axitinib inhibits the activity of multiple tyrosine kinases in renal cell carcinoma, especially vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3). By blocking these signaling pathways, it inhibits tumor angiogenesis and slows the rate at which tumors grow and spread.
3. Pharmacology (Pharmacology):
Axitinib is a targeted therapy that selectively acts on specific kinase pathways. It is rapidly absorbed in the body upon oral administration, with the time to reach maximum plasma concentrations typically being 2-4 hours. The metabolism of axitinib occurs mainly in the liver, forming major metabolites.
4. Dosage and Administration (Dosage and Administration):
1.Patients should use axitinib under the guidance of a doctor.
2.The usual dosage is oral administration 2 times daily, and it is recommended to take it at least 2 hours after breakfast and dinner.
3.The dosage of the drug may be adjusted according to the patient's specific condition, so please do not change the medication regimen on your own.

5. Side effects (Side Effects):
The use of axitinib may cause a series of side effects, including but not limited to:
1.Hypertension: Patients need to measure their blood pressure regularly during treatment.
2.Hand-foot syndrome: Including redness, swelling, pain, etc. in the hands and feet.
3.Proteinuria: May cause elevated protein levels in urine.
4.Fatigue: Patients may feel tired and weak.
5.Headache, insomnia, loss of appetite, etc.
Patients should pay close attention to these side effects during medication and report any discomfort to their doctor promptly.
6. Warnings and Precautions (Warnings and Precautions):
1.Patients should be regularly monitored and evaluated by a doctor during medication.
2.Pay attention to monitor blood pressure and take antihypertensive measures when necessary.
3.Drugs may cause cardiovascular events, and patients need to be particularly careful.
4.Axitinib may cause bleeding, so patients should avoid taking other drugs that affect clotting.
7. Contraindications (Contraindications):
1.Patients who are allergic to axitinib or its components.
2.Pregnant and lactating women.
8. Drug Interactions (Drug Interactions):
Axitinib may interact with other drugs that affect blood coagulation. Patients should inform their doctors about other drugs they are taking, including prescription and over-the-counter drugs, before taking the drug.
9. Medication for special populations (Special Populations):
1.Contraindicated for pregnant women. Female patients must take effective contraceptive measures during treatment.
2.In elderly patients and patients with impaired hepatic function, the dose of axitinib may need to be adjusted.
10. Listing and price situation:
Axitinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price of 5mg*28 tablets is about 5,000 to 6,000 yuan. For specific prices, please consult the local hospital pharmacy. There are original and generic axitinib drugs abroad. The original drug is Pfizer's original drug, and the price is about 6,000 yuan; the generic drugs are mainly Bangladeshi generics and Indian generics. The price of Bangladeshi generics in 5mg*60 tablets is more than 1,000 yuan, and the price of Indian generics is around a few hundred yuan. The ingredients of original drugs and generic drugs are basically the same.
In general, patients should understand their doctor's recommendations in detail before using axitinib and follow the doctor's instructions to use the medication correctly. During the period of medication, be monitored and evaluated by a doctor regularly, and report any abnormal symptoms in a timely manner to ensure the effectiveness and safety of the treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)